BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 19157505)

  • 1. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
    Ahmad I; Iyer A; Marginean CE; Yeh MM; Ferrell L; Qin L; Bifulco CB; Jain D
    Hum Pathol; 2009 May; 40(5):726-34. PubMed ID: 19157505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance.
    Iyer A; Robert ME; Bifulco CB; Salem RR; Jain D
    Hum Pathol; 2008 Sep; 39(9):1370-7. PubMed ID: 18602664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telangiectatic variant of hepatic adenoma: clinicopathologic features and correlation between liver needle biopsy and resection.
    Mounajjed T; Wu TT
    Am J Surg Pathol; 2011 Sep; 35(9):1356-63. PubMed ID: 21836491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy.
    Kong CS; Appenzeller M; Ferrell LD
    Acta Cytol; 2000; 44(2):218-22. PubMed ID: 10740609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
    Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
    Swanson BJ; Yearsley MM; Marsh W; Frankel WL
    Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.
    Bioulac-Sage P; Cubel G; Taouji S; Scoazec JY; Leteurtre E; Paradis V; Sturm N; Nhieu JT; Wendum D; Bancel B; Ramos J; Paraf F; Saint Paul MC; Michalak S; Fabre M; Guettier C; Le Bail B; Zucman-Rossi J; Balabaud C
    Am J Surg Pathol; 2012 Nov; 36(11):1691-9. PubMed ID: 23060349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
    Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S
    Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions.
    Heukamp LC; Fischer HP; Schirmacher P; Chen X; Breuhahn K; Nicolay C; Büttner R; Gütgemann I
    Histopathology; 2006 Sep; 49(3):242-7. PubMed ID: 16918970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
    de Boer WB; Segal A; Frost FA; Sterrett GF
    Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostaining of glutamine synthetase is a sensitive and specific marker for diagnosing focal nodular hyperplasia in needle biopsy.
    Tsai JH; Jeng YM; Pan CC; Lu SW; Kuo YJ
    Pathology; 2012 Dec; 44(7):605-10. PubMed ID: 22990279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
    Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
    J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.
    Ruck P; Xiao JC; Kaiserling E
    Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic adenoma and focal nodular hyperplasia.
    Shortell CK; Schwartz SI
    Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis.
    Gouysse G; Frachon S; Hervieu V; Fiorentino M; d'Errico A; Dumortier J; Boillot O; Partensky C; Grigioni WF; Scoazec JY
    J Hepatol; 2004 Aug; 41(2):259-66. PubMed ID: 15288475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
    Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
    Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of focal nodular hyperplasia of the liver by needle biopsy.
    Makhlouf HR; Abdul-Al HM; Goodman ZD
    Hum Pathol; 2005 Nov; 36(11):1210-6. PubMed ID: 16260275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic challenges of focal nodular hyperplasia: interobserver variability, accuracy, and the utility of glutamine synthetase immunohistochemistry.
    Rowan DJ; Allende DS; Bellizzi AM; Gill RM; Liu X; McKenzie CA; Moreira RK; Mounajjed T; Said S; Westerhoff M; Jenkins SM; Batts KP; Burgart LJ; Lamps LW; Graham RP
    Histopathology; 2021 Nov; 79(5):791-800. PubMed ID: 34080211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions.
    Tátrai P; Somorácz A; Batmunkh E; Schirmacher P; Kiss A; Schaff Z; Nagy P; Kovalszky I
    Am J Surg Pathol; 2009 Jun; 33(6):874-85. PubMed ID: 19194276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.